Apsis | Jotup

Apogee Therapeutics to Participate in Upcoming June Investor Conferences

Retrieved on:

목요일, 5월 23, 2024

News, Atopic dermatitis, Therapy, Asthma, SAN, COPD, Apsis

SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that members of management will participate at the following upcoming investor conferences:

Key Points:

SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that members of management will participate at the following upcoming investor conferences:
A live and archived webcast of the fireside chat and presentation will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

Eureka College Expands Technology Partnership with Apogee, Adding Apogee Managed Campus Services

Retrieved on:

화요일, 5월 21, 2024

This expanded partnership includes Apogee Managed Campus, its suite of Managed Network, Security, Cloud, Professional, and IT services.

Key Points:

This expanded partnership includes Apogee Managed Campus, its suite of Managed Network, Security, Cloud, Professional, and IT services.
Designed to comprehensively address the IT services needs of higher education institutions, Apogee Managed Campus builds on the successful implementations of Apogee ResNet and Apogee Managed Network Services that were initiated at Eureka College in 2019.
2024: Eureka College expanded its partnership to include Apogee Managed Campus, its comprehensive suite of Managed Networks, Security, Cloud, Professional, and IT services.
In early 2024, Apogee expanded its partnership with Eureka College to provide Apogee Managed Campus Services to address the institution’s IT services needs more fully.

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

Retrieved on:

월요일, 5월 6, 2024

News, Conference, Apsis, Bank, Atopic dermatitis, Therapy, Asthma, SAN, COPD

SAN FRANCISCO and WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that Michael Henderson, M.D., Chief Executive Officer and Jane Pritchett Henderson, Chief Financial Officer, will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 3:40 p.m. P.T.

Key Points:

SAN FRANCISCO and WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that Michael Henderson, M.D., Chief Executive Officer and Jane Pritchett Henderson, Chief Financial Officer, will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 3:40 p.m. P.T.
/ 6:40 p.m. E.T.
A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

Apogee Enterprises Reports Fiscal 2024 Fourth Quarter and Full Year Results

Retrieved on:

목요일, 4월 18, 2024

Architecture, Commercial Building & Real Estate, Construction & Property, Other Manufacturing, Building Systems, REIT, Other Construction & Property, Manufacturing, Corporation, Central Time, Webcast, Capital expenditure, Public expenditure, Apsis, EPS, Glass, Fortify, Pharmaceutical industry

During the fourth quarter, the Company incurred $12.4 million of pre-tax charges related to Project Fortify.

Key Points:

During the fourth quarter, the Company incurred $12.4 million of pre-tax charges related to Project Fortify.
The Company expects approximately 60% of these savings will be realized in fiscal 2025, and the remainder in fiscal 2026.
Segment backlog at the end of the quarter was $807.8 million, a 4.0% increase compared to $776.5 million at the end of the third fiscal quarter.
Net cash provided by operating activities in the fourth quarter improved to $74.9 million, compared to $51.6 million in last year’s fourth quarter.

Apogee Minerals Announces Amendment to Option Agreement for the Pine Channel Property

Retrieved on:

목요일, 3월 28, 2024

Pine, Apsis, TSX Venture Exchange, TSX, CAD

Vancouver, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) has amended the option agreement (the “Amendment Agreement”) with Eagle Plains (the “Optionor”) whereby the Optionor granted the Company the right to acquire up to an 80% interest in the Pine Channel Property (the “Property”).

Key Points:

Vancouver, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) has amended the option agreement (the “Amendment Agreement”) with Eagle Plains (the “Optionor”) whereby the Optionor granted the Company the right to acquire up to an 80% interest in the Pine Channel Property (the “Property”).
The new exploration expenditure schedule is as follows:
$500,000 on or before June 30, 2025; and
$2,000,000 on or before December 31, 2025.
In consideration of the amendment, Apogee shall issue the Optionor 50,000 common shares within three (3) business days of receipt of TSX Venture Exchange approval of the Amendment Agreement.
The shares issued shall be subject to a statutory hold period of four months and one day from issuance.

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

Retrieved on:

화요일, 3월 12, 2024

The aggregate gross proceeds to Apogee from the offering were approximately $483.0 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee.

Key Points:

The aggregate gross proceeds to Apogee from the offering were approximately $483.0 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee.
All of the shares were offered by Apogee.
Jefferies, BofA Securities, Goldman Sachs & Co. LLC, TD Cowen and Stifel acted as joint book-running managers for the offering.
Registration statements relating to these securities have been filed with the Securities and Exchange Commission and became effective on March 7, 2024.

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering

Retrieved on:

목요일, 3월 7, 2024

The aggregate gross proceeds to Apogee from the offering are expected to be approximately $420.0 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee, excluding any exercise of the underwriters’ option to purchase additional shares.

Key Points:

The aggregate gross proceeds to Apogee from the offering are expected to be approximately $420.0 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee, excluding any exercise of the underwriters’ option to purchase additional shares.
The offering is expected to close on March 12, 2024, subject to the satisfaction of customary closing conditions.
In addition, Apogee has granted the underwriters a 30-day option to purchase up to an additional 1,016,128 shares of common stock at the public offering price, less underwriting discounts and commissions.
Jefferies, BofA Securities, Goldman Sachs & Co. LLC, TD Cowen and Stifel are acting as joint book-running managers for the offering.

Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering

Retrieved on:

화요일, 3월 5, 2024

Attention, SAN, Apsis, Lexington Avenue, Jefferies Group, Suite, Telephone, Atopic dermatitis, Asthma, Sale, Montgomery Street, Chronic obstructive pulmonary disease, Therapy, Madison Avenue, BofA Securities, Security (finance), Goldman Sachs, Jefferies

In addition, Apogee expects to grant the underwriters a 30-day option to purchase up to an additional $52.5 million of shares of common stock at the public offering price, less underwriting discounts and commissions.

Key Points:

In addition, Apogee expects to grant the underwriters a 30-day option to purchase up to an additional $52.5 million of shares of common stock at the public offering price, less underwriting discounts and commissions.
The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
Jefferies, BofA Securities, Goldman Sachs & Co. LLC, TD Cowen, and Stifel are acting as joint book-running managers for the proposed offering.
This offering will be made only by means of a written prospectus.

EnergyX is Acquired by Apogee Interactive to Enhance Platform That Improves Energy Savings Programs for Utilities

Retrieved on:

수요일, 2월 7, 2024

Apsis, Acquisition, Growth, Sales

TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Apogee Interactive announced today the acquisition of EnergyX Solutions, Inc. , an Ontario-based creator of artificial-intelligence-powered software for utilities.

Key Points:

TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Apogee Interactive announced today the acquisition of EnergyX Solutions, Inc. , an Ontario-based creator of artificial-intelligence-powered software for utilities.
Operating in the United States and Canada, EnergyX leverages data science to increase customer participation in energy efficiency programs.
EnergyX's RetrofitAI technology enables utilities to perform cost-effective virtual building audits at scale across their entire service territory resulting in increased customer segmentation, targeting, and energy efficiency program uptake.
“Joining the extended Apogee team is a great fit for EnergyX, as we specialize in customer journey software for utility customers, streamlining the identification of ideal targets for energy savings programs,” said Nishaant Sangaavi, President of EnergyX.

Anitra Simmons Named Operations Director of Apogee Mission Operations

Retrieved on:

목요일, 1월 4, 2024

Workforce, Hospital, MAJCOM, University, Sociology, Air force, The King's Daughters, Education, College, Federation, Apsis, Mental health, Professional, Daughter, Volunteering, Anthropology, DHS, CHKD, Management

COLORADO SPRINGS, Colo., Jan. 4, 2024 /PRNewswire/ -- Apogee, a leading defense and security solutions provider, announced the promotion of Anitra Simmons to director of operations for its Mission Operations portfolio effective Nov. 1, 2023.

Key Points:

COLORADO SPRINGS, Colo., Jan. 4, 2024 /PRNewswire/ -- Apogee, a leading defense and security solutions provider, announced the promotion of Anitra Simmons to director of operations for its Mission Operations portfolio effective Nov. 1, 2023.
In this role Simmons will lead program implementation and support federal government business development for Apogee's Mission Operations portfolio which is focused on U.S. Department of Defense (DoD) and Department of Homeland Security (DHS) programs.
The company's mission operations include 15 projects and 118 employees across Federal Agency Operations, Air Force (AF) Operations and Sustainment, and AF Major Commands (MAJCOM) Staff programs.
"Anitra has continually dedicated herself to the mission of our customers and maintains the highest level of professionalism with our workforce and within our local communities.